Full-Time

Clinical Account Manager

Confirmed live in the last 24 hours

Ceribell

Ceribell

201-500 employees

EEG devices for monitoring brain activity

Compensation Overview

$100k - $180k/yr

+ Uncapped Commission Potential + Ceribell Equity

Mid, Senior

Omaha, NE, USA

Category
Customer Success
Sales & Account Management
Requirements
  • 3-5 years of recent critical care sales experience OR 5 years and med device or pharma experience OR RN’s with industry experience in supporting sales teams.
  • Experience working with multiple key stakeholders (physicians, management, administration) or hospital-wide committee membership.
  • Excellent Communicator, Relationship Builder, Creative & Effective Problem Solver, highly organized and ability to prioritize strategically.
  • Ability to accurately assess and understand different stakeholders needs/wants. Process cross functional agendas and adjust strategy to achieve desired outcomes.
  • Confidence and expertise required to effectively challenge the status quo and influence meaningful change through consensus building.
  • Driven & Coachable: innate desire to succeed; willing to seek out coaching, accept feedback and apply new skills supports measurable change.
  • Grit, high integrity.
Responsibilities
  • Expand use of Ceribell to additional acute or critical care centers within existing customer base.
  • Work with the local Territory Manager to launch Ceribell at new customer sites.
  • Drive new product and technology introductions for existing customers.
  • Build advocacy and champions within facilities. Use hospital data to validate and build interest.
  • Develop a qualified lead funnel within existing install base. Regular activities consist of formal presentations, peer to peer education, new physician training, and driving physician education.
  • Responsible for upgrades and departmental expansion in existing install base.
  • Educate and train physicians, hospital personnel and/or office staff on the merits and proper clinical usage of company products. Become a clinical expert in use cases of Ceribell and relevant patient populations.
  • Troubleshoot workflow solutions for departments as need arises.
  • Partner with clinicians to identify and establish protocols for patients at risk of seizure.
  • Lead clinical teams through training sessions helping understand workflow and applications.
  • Submit all required reports and training documentation on a timely basis.
  • Use Salesfoce.com to manage administrative task.
  • Ensure compliance with applicable laws, regulations, and Ceribell policies.
  • Works cross-functionally to ensure successful deployment of Ceribell products at customer locations.
  • Ability to work within a field-based team and strong partnership with Territory Manager of respective region.
Desired Qualifications
  • Bonus points: start-up experience or experience working with disruptive technology, med device experience, neuro ICU clinical experience, sales experience.

Ceribell focuses on developing medical devices that utilize electroencephalogram (EEG) technology to monitor brain activity. Their main product, the Ceribell EEG Headband and Recorder, is designed for use by trained healthcare providers in professional settings. These devices help gather important data on brain activity, which is essential for diagnosing and treating neurological conditions, particularly in urgent situations like Nonconvulsive Status Epilepticus (NCSE). Unlike some other medical devices, the Ceribell EEG Recorder does not provide diagnostic conclusions or automated alerts; instead, it serves as a tool for healthcare professionals to collect data for interpretation. Ceribell generates revenue by selling these devices to healthcare providers, adhering to regulations that require physician orders for their use. The company's goal is to enhance the speed and effectiveness of treatment for patients experiencing critical neurological events.

Company Size

201-500

Company Stage

Series C

Total Funding

$171M

Headquarters

Mountain View, California

Founded

2014

Simplify Jobs

Simplify's Take

What believers are saying

  • AI integration in EEG systems is gaining traction, benefiting Ceribell's technology.
  • The global EEG devices market is projected to grow at a CAGR of 8.7% until 2030.
  • FDA's focus on AI-driven medical devices could expedite Ceribell's market entry.

What critics are saying

  • Increased competition from emerging EEG technologies could impact Ceribell's market share.
  • The expiration of Ceribell's lock-up period may lead to stock volatility.
  • Recent earnings reports missing estimates could affect investor confidence.

What makes Ceribell unique

  • Ceribell's EEG system offers instant results without needing a specialist interpreter.
  • The Brain Stethoscope function converts brainwaves to sound for easy seizure detection.
  • Ceribell's EEG system can be set up by any healthcare provider in 6 minutes.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Unlimited Paid Time Off

Paid Holidays

Parental Leave

Annual Bonus Opportunity

Company Equity

Phone/Internet Stipend

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

2%
Zolmax
Apr 8th, 2025
CeriBell's $180M Lock-Up Expires Tomorrow

CeriBell's (NASDAQ:CBLL) lock-up period ends on April 9th, allowing major shareholders and insiders to trade shares. The company issued 10,606,060 shares in its IPO on October 11th, raising $180 million at $17 per share. Analysts have given CBLL a consensus "Buy" rating with a $32.50 price target. The stock opened at $18.19, with a 52-week range of $17.24 to $32.75. Recent earnings missed estimates, reporting a loss of $0.40 per share on $18.53 million revenue.

BioSpace
Nov 20th, 2024
Ceribell Appoints Kristie Rodenbush As Chief People Officer And Brian Price As Senior Vice President Of Marketing

—Ms. Rodenbush to lead hiring and talent development initiatives— —Mr. Price to focus on market development and penetration— SUNNYVALE, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions (“Ceribell”), today announced the appointments of Kristie Rodenbush as Chief People Officer and Brian Price as Senior Vice President of Marketing to its leadership team. “Ms

Fierce Biotech
Oct 15th, 2024
Ceribell CEO Jane Chao explains why now was the time for its upsized IPO

Ceribell, a former Fierce Medtech Fierce 15 honoree, has been developing a point-of-care electroencephalography platform that combines a disposable, brain-reading headset with artificial intelligence-powered algorithms that help detect hidden seizures-also known as electrographic status epilepticus, or ESE.

Renaissance Capital
Oct 7th, 2024
Seizure diagnostic company CeriBell sets terms for $101 million IPO

CeriBell, a medical device maker with an EEG platform that uses AI to monitor patient seizures, announced terms for its IPO on Monday.

PR Newswire
Apr 2nd, 2024
Ceribell Appoints Sean Manni As Senior Vice President Of Sales

Healthcare sales veteran to lead sales strategies and initiatives to propel continued commercial growthSUNNYVALE, Calif., April 2, 2024 /PRNewswire/ -- Today, Ceribell, Inc.®, the developer of the first AI-powered point-of-care EEG diagnostic system, announced the appointment of Sean Manni as Senior Vice President of Sales. In this role, Mr. Manni will lead Ceribell's commercial sales organization as it continues to expand its U.S. footprint."Sean brings an impressive blend of accomplishments, strategy, and leadership that will undoubtedly elevate our entire commercial organization," said Ceribell co-founder and CEO Jane Chao, Ph.D. "His guidance will be instrumental in developing and executing our plans to further expand our market presence in the U.S., ultimately benefiting patients by increasing access to our groundbreaking technology.""Joining Ceribell represents a unique opportunity to collaborate with an exceptional leadership and sales team," said Manni. "I am deeply committed to leveraging my experience in healthcare sales to further innovate Ceribell's sales strategies and ensure our revolutionary AI-powered point-of-care EEG solutions reach patients in need."Mr